Key Takeaways
- NYSE Arca and NYSE American eliminated the 25,000-contract restriction on options for 11 cryptocurrency ETFs
- SEC approval came with an expedited implementation timeline, bypassing the typical 30-day review window
- Impacted products include ETFs from BlackRock (IBIT), Fidelity (FBTC), ARK 21Shares, Grayscale, and Bitwise
- Cryptocurrency ETF options now qualify for FLEX trading with customizable contract specifications
- All primary U.S. options trading venues have now eliminated these restrictions
NYSE Arca and NYSE American submitted regulatory amendments to the Securities and Exchange Commission eliminating the 25,000-contract restriction on options contracts linked to 11 Bitcoin and Ether exchange-traded funds. The SEC granted an expedited approval, bypassing the typical 30-day implementation window and allowing immediate effectiveness.
The 25,000-contract restriction was originally implemented in November 2024 during the initial launch of cryptocurrency ETF options trading. Regulators established this threshold as a protective measure aimed at preventing excessive market manipulation and limiting volatility exposure.
The regulatory modifications apply to 11 distinct cryptocurrency ETF offerings. The roster includes BlackRock’s iShares Bitcoin Trust, Fidelity’s Wise Origin Bitcoin Fund, ARK 21Shares Bitcoin ETF, Grayscale’s Bitcoin and Ethereum trust products, and Bitwise’s Bitcoin and Ethereum exchange-traded funds.
Eliminating the restriction aligns cryptocurrency ETF options with existing regulatory treatment of commodity-based ETF derivatives at major trading venues. Options contracts on substantial, highly-liquid ETFs can now achieve position thresholds of 250,000 contracts or higher under conventional exchange protocols.
The amendments additionally authorize these investment vehicles to operate as FLEX options products. FLEX options provide market participants the ability to negotiate bespoke contract specifications, encompassing non-conventional strike prices, maturity dates, and exercise mechanisms.
During IBIT’s inaugural options trading session in November 2024, Bloomberg senior ETF analyst Eric Balchunas observed the product generated approximately $1.9 billion in notional value despite operating under the contract restriction.
In October 2024, Kbit CEO Ed Tolson commented that the restriction wasn’t excessively limiting considering the $40 billion in Bitcoin open interest spanning futures and perpetual swap markets during that period. However, market participants viewed the limitation as inconsistent with treatment of comparable commodity ETF products.
Coordinated Exchange Transition Reaches Completion
Several trading platforms had previously taken action to eliminate the restriction ahead of NYSE’s decision. Nasdaq ISE and Nasdaq PHLX submitted regulatory filings to remove limitations in January. MIAX pursued identical measures during the same timeframe. MEMX submitted its proposal in February. Cboe filed its corresponding version in March.
With NYSE Arca and NYSE American finalizing their regulatory submissions, every significant U.S. options trading platform has now removed the restriction.
The SEC acknowledged the proposals present no novel regulatory challenges, referencing the identical modifications already operational at competing exchanges.
Institutional Trading Implications
Eliminating the position restriction enables institutional market participants to implement more sophisticated hedging approaches, basis trading strategies, and portfolio overlay frameworks. Availability of FLEX options permits institutions to structure customized contract specifications for complex derivative products.
This operational flexibility existed previously for comparable commodity ETF products such as the SPDR Gold Trust and iShares Silver Trust, but remained unavailable for cryptocurrency ETF options until this development.
In a separate regulatory matter, Nasdaq ISE has submitted a pending proposal to elevate the position threshold exclusively for BlackRock’s IBIT to 1 million contracts. The SEC continues evaluating that submission, which has undergone five amendments to date. The public comment window for both NYSE regulatory filings concludes on April 13.
